HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer (mCRC) refractory to anti-EGFR antibodies.
| Autor: | Ishiguro, Atsushi, Nakatsumi, Hiroshi, Harada, Kazuaki, Yuki, Satoshi, Sawada, Kentaro, Sogabe, Susumu, Ando, Takayuki, Sasaki, Yusuke, Yoshikawa, Ayumu, Nakamura, Michio, Dazai, Masayoshi, Tateyama, Miki, Muto, Osamu, Kotaka, Masahito, Sagawa, Tamotsu, Hatanaka, Kazuteru, Takagi, Ryo, Sakata, Yuh, Komatsu, Yoshito |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p113-113, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|